搜尋





搜尋





TScan Therapeutics Inc

TCRX

添加自選

0.355USD

+0.024+7.25%

收盤 09-22 16:00（美東）

23.72M總市值

虧損本益比TTM

盤後交易 18:05 (美東)0.359USD+0.007+1.99%

TScan Therapeutics Inc

0.355

+0.024+7.25%

財務摘要利潤表資產負債表現金流量表公司收入財報公司估值風險評估

概覽

財務

股票評分

技術分析

預測

持股情況

股息

公司資料

財務摘要利潤表資產負債表現金流量表公司收入財報公司估值風險評估

TCRX 利潤表

您可以在這裡找到TScan Therapeutics Inc的年度或季度收入報告，以深入了解TScan Therapeutics Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

營業總收入

-65.83%1.05M

-54.77%982.00K

286.02%2.57M

139.37%2.51M

473.88%3.08M

283.57%2.17M

-90.78%665.00K

-73.01%1.05M

-82.97%536.00K

-91.68%566.00K

132.99%7.21M

15.58%3.89M

-22.39%3.15M

125.19%6.80M

8.44%3.10M

39.43%3.36M

42.42%4.06M

49.04%3.02M

258.99%2.85M

731.72%2.41M

--2.85M

--2.03M

--795.00K

--290.00K

--0.00

營業收入

-65.83%1.05M

-54.77%982.00K

286.02%2.57M

139.37%2.51M

473.88%3.08M

283.57%2.17M

-90.78%665.00K

-73.01%1.05M

-82.97%536.00K

-91.68%566.00K

132.99%7.21M

15.58%3.89M

-22.39%3.15M

125.19%6.80M

8.44%3.10M

39.43%3.36M

42.42%4.06M

49.04%3.02M

258.99%2.85M

731.72%2.41M

--2.85M

--2.03M

--795.00K

--290.00K

--0.00

營業費用

-24.41%31.54M

-21.60%30.12M

-34.65%24.43M

17.50%39.56M

20.43%41.73M

20.29%38.42M

30.84%37.38M

17.59%33.67M

24.83%34.65M

8.10%31.94M

31.38%28.57M

43.60%28.64M

43.81%27.76M

54.01%29.55M

27.49%21.74M

9.24%19.94M

42.69%19.30M

92.90%19.18M

98.21%17.06M

144.66%18.25M

140.87%13.53M

76.45%9.95M

--8.61M

--7.46M

--5.62M

--5.64M

研發費用

-29.04%22.79M

-27.29%21.30M

-39.21%17.84M

18.41%31.10M

19.48%32.11M

17.82%29.29M

31.01%29.35M

15.48%26.26M

26.62%26.88M

14.13%24.86M

43.59%22.41M

51.29%22.74M

46.45%21.23M

48.26%21.78M

23.76%15.60M

5.81%15.03M

34.19%14.49M

100.16%14.69M

111.40%12.61M

144.38%14.21M

139.92%10.80M

70.75%7.34M

--5.96M

--5.81M

--4.50M

--4.30M

折舊攤銷及損耗

0.14%699.00K

2.21%693.00K

1.69%723.00K

-25.32%767.00K

-37.46%698.00K

-45.93%678.00K

-44.45%711.00K

-20.14%1.03M

-13.89%1.12M

-16.34%1.25M

-13.75%1.28M

2.80%1.29M

7.37%1.30M

25.44%1.50M

29.95%1.48M

18.47%1.25M

82.60%1.21M

154.80%1.20M

188.38%1.14M

205.20%1.06M

148.50%661.00K

111.26%469.00K

--396.00K

--346.00K

--266.00K

--222.00K

營業利潤

21.11%-30.49M

19.62%-29.14M

40.46%-21.86M

-13.58%-37.05M

-13.31%-38.65M

-15.55%-36.25M

-71.90%-36.71M

-31.82%-32.62M

-38.62%-34.11M

-37.95%-31.37M

-14.52%-21.36M

-49.28%-24.75M

-61.42%-24.61M

-40.71%-22.74M

-31.31%-18.65M

-4.65%-16.58M

-42.77%-15.25M

-104.13%-16.16M

-81.84%-14.20M

-120.92%-15.84M

-90.15%-10.68M

-40.49%-7.92M

---7.81M

---7.17M

---5.62M

---5.64M

淨非營業利息收入（費用）

利息收入

-65.15%833.00K

-58.53%1.16M

-43.00%1.58M

-44.73%2.04M

-29.81%2.39M

27.95%2.80M

6.97%2.78M

35.13%3.69M

121.97%3.41M

92.78%2.19M

188.12%2.60M

411.80%2.73M

929.53%1.53M

16128.57%1.14M

44950.00%901.00K

17700.00%534.00K

2880.00%149.00K

16.67%7.00K

-33.33%2.00K

200.00%3.00K

66.67%5.00K

-93.94%6.00K

--3.00K

--1.00K

--3.00K

--99.00K

利息費用

1.45%699.00K

1.47%689.00K

-10.46%702.00K

-27.04%699.00K

-27.63%689.00K

-29.20%679.00K

-7.98%784.00K

-2.44%958.00K

-1.75%952.00K

0.31%959.00K

-12.62%852.00K

388.56%982.00K

--969.00K

--956.00K

--975.00K

--201.00K

----

特殊收入（費用）

----

-83.49%-2.00M

----

---1.09M

----

稅前利潤

17.84%-30.36M

16.00%-28.67M

35.83%-22.98M

-19.48%-35.71M

-16.71%-36.95M

-13.22%-34.13M

-82.58%-35.81M

-29.96%-29.89M

-31.67%-31.66M

-33.59%-30.14M

-4.75%-19.61M

-41.56%-23.00M

-59.27%-24.05M

-39.66%-22.56M

-31.85%-18.72M

-2.56%-16.25M

-41.44%-15.10M

-104.20%-16.16M

-81.89%-14.20M

-120.91%-15.84M

-90.17%-10.67M

-42.89%-7.91M

---7.81M

---7.17M

---5.61M

---5.54M

除稅後利潤

17.84%-30.36M

16.00%-28.67M

35.83%-22.98M

-19.48%-35.71M

-16.71%-36.95M

-13.22%-34.13M

-82.58%-35.81M

-29.96%-29.89M

-31.67%-31.66M

-33.59%-30.14M

-4.75%-19.61M

-41.56%-23.00M

-59.27%-24.05M

-39.66%-22.56M

-31.85%-18.72M

-2.56%-16.25M

-41.44%-15.10M

-104.20%-16.16M

-81.89%-14.20M

-120.91%-15.84M

-90.17%-10.67M

-42.89%-7.91M

---7.81M

---7.17M

---5.61M

---5.54M

持續經營利潤

17.84%-30.36M

16.00%-28.67M

35.83%-22.98M

-19.48%-35.71M

-16.71%-36.95M

-13.22%-34.13M

-82.58%-35.81M

-29.96%-29.89M

-31.67%-31.66M

-33.59%-30.14M

-4.75%-19.61M

-41.56%-23.00M

-59.27%-24.05M

-39.66%-22.56M

-31.85%-18.72M

-2.56%-16.25M

-41.44%-15.10M

-104.20%-16.16M

-81.89%-14.20M

-120.91%-15.84M

-90.17%-10.67M

-42.89%-7.91M

---7.81M

---7.17M

---5.61M

---5.54M

歸属于母公司的淨利潤

17.84%-30.36M

16.00%-28.67M

35.83%-22.98M

-19.48%-35.71M

-16.71%-36.95M

-13.22%-34.13M

-82.58%-35.81M

-29.96%-29.89M

-31.67%-31.66M

-33.59%-30.14M

-4.75%-19.61M

-41.56%-23.00M

-59.27%-24.05M

-39.66%-22.56M

-31.85%-18.72M

-2.56%-16.25M

-41.44%-15.10M

-104.20%-16.16M

-81.89%-14.20M

-120.91%-15.84M

-90.17%-10.67M

-42.89%-7.91M

---7.81M

---7.17M

---5.61M

---5.54M

歸屬普通股東的淨利潤

17.84%-30.36M

16.00%-28.67M

35.83%-22.98M

-19.48%-35.71M

-16.71%-36.95M

-13.22%-34.13M

-82.58%-35.81M

-29.96%-29.89M

-31.67%-31.66M

-33.59%-30.14M

-4.75%-19.61M

-41.56%-23.00M

-59.27%-24.05M

-39.66%-22.56M

-31.85%-18.72M

-2.56%-16.25M

-41.44%-15.10M

-104.20%-16.16M

-81.89%-14.20M

-120.91%-15.84M

-90.17%-10.67M

-42.89%-7.91M

---7.81M

---7.17M

---5.61M

---5.54M

基本每股收益

17.98%-0.23

16.16%-0.22

40.29%-0.18

-9.23%-0.28

-2.04%-0.28

17.16%-0.26

-43.92%-0.30

-3.83%-0.25

45.19%-0.28

65.89%-0.32

73.52%-0.21

64.06%-0.24

18.82%-0.51

-38.21%-0.93

-29.17%-0.78

-0.49%-0.67

-38.64%-0.63

-100.90%-0.67

-81.89%-0.60

-120.91%-0.67

-90.17%-0.45

-42.89%-0.34

---0.33

---0.30

---0.24

---0.23

稀釋每股收益

17.98%-0.23

16.16%-0.22

40.29%-0.18

-9.23%-0.28

-2.04%-0.28

17.16%-0.26

-43.92%-0.30

-3.83%-0.25

45.19%-0.28

65.89%-0.32

73.52%-0.21

64.06%-0.24

18.82%-0.51

-38.21%-0.93

-29.17%-0.78

-0.49%-0.67

-38.64%-0.63

-100.90%-0.67

-81.89%-0.60

-120.91%-0.67

-90.17%-0.45

-42.89%-0.34

---0.33

---0.30

---0.24

---0.23

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 TScan Therapeutics Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 TCRX 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

TScan Therapeutics Inc 財年末的營收是多少？



TScan Therapeutics Inc 2025 財年營收為 10.32M，高於上一財年的 2.82M。

TScan Therapeutics Inc 最近一個季度的營收是多少？



TScan Therapeutics Inc 最近一個季度的營收為 1.05M，同比增長 -65.83%。

TScan Therapeutics Inc 全年的淨利潤是多少？



TScan Therapeutics Inc 2025 財年淨利潤為 -129.77M。

TScan Therapeutics Inc 上一季度的淨利潤是多少？



TScan Therapeutics Inc 最近一個季度的淨利潤為 -30.36M。

TScan Therapeutics Inc 年度營業利潤是多少？



TScan Therapeutics Inc 2025 財年的營業利潤為 -133.81M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。